Antibody Drug Conjugate

Antibody Drug Conjugates (ADCs) are a class of drugs in which monoclonal antibodies are conjugated with Highly Active Pharmaceutical Ingredients (HAPIs). ADCs are particularly effective because they exhibit selective cytotoxicity by targeting only a small subset of cells. BioReliance, along with SAFC, offers comprehensive and coordinated services for the development, manufacture, and testing of your ADC.

BioReliance has years of experience in the production and testing of monoclonal antibodies (mAb), giving us the ability to provide complete testing for the bulk mAb product. SAFC offers a whole suite of services needed for ADCs including: